Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma

Jinyu Zhu; Bufu Tang; Jie Li; Yueli Shi; Minjiang Chen; Xiuling Lv; Miaomiao Meng; Qiaoyou Weng; Nannan Zhang; Kai Fan; Min Xu; Jiansong Ji

doi:doi:10.18632/aging.103107

← Back

Research Paper Volume 12, Issue 9 pp 7848—7873

Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma

Figure 12. Molecular mechanism of piperlongumine to achieve antitumor effect. (A) The interaction of the corresponding encoded proteins of 226 angiogenic genes regulated by piperlongumine. (B–C) The GO analysis (B) and the KEGG pathway analysis (C) of the 226 angiogenic genes. (D–E) Western blot analysis of SK-HEP1 (D) and SMMC-7721 (E) cell lines.